Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 16, 2023 17:13 ET | Source: Portnoy Law

Spectrum Pharmaceuticals, Inc.: Please contact the Portnoy Law Firm to recover your losses; February 3, 2023 deadline

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Jan. 16, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Spectrum Pharmaceuticals, Inc....
January 13, 2023 23:00 ET | Source: Kaplan Fox & Kilsheimer LLP

Kaplan Fox Reminds Investors with Losses in Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI) of February 3, 2023 Lead Plaintiff Deadline

NEW YORK, Jan. 13, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) filed a proposed class action suit in the United States District Court for the Southern District of...
December 28, 2022 17:18 ET | Source: Robbins LLP

Class Action Involving Spectrum Pharmaceuticals, Inc. (SPPI): Contact Robbins LLP if You Incurred Significant Financial Harm from Your Investment in Spectrum Pharmaceuticals, Inc.

SAN DIEGO, Dec. 28, 2022 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all purchasers of Spectrum Pharmaceuticals, Inc. (NASDAQ:...
December 14, 2022 17:18 ET | Source: Robbins LLP

Spectrum Pharmaceuticals, Inc. (SPPI) Equity Alert: Contact Robbins LLP for Information About the Class Action Against Spectrum Pharmaceuticals, Inc.

SAN DIEGO, Dec. 14, 2022 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all purchasers of Spectrum Pharmaceuticals, Inc. (NASDAQ:...
December 08, 2022 12:42 ET | Source: Robbins LLP

Spectrum Pharmaceuticals, Inc. (SPPI) Shareholder Alert: Robbins LLP Reminds Investors of Class Action Against Spectrum Pharmaceuticals, Inc.

SAN DIEGO, Dec. 08, 2022 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all purchasers of Spectrum Pharmaceuticals, Inc. (NASDAQ:...
December 05, 2022 21:40 ET | Source: Kaplan Fox & Kilsheimer LLP

Kaplan Fox Files Class Action to Recover Losses for Investors Who Purchased Common Stock of Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI)

NEW YORK, Dec. 05, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has filed a proposed class action suit in the United States District Court for the Southern District...
December 02, 2022 15:32 ET | Source: Kaplan Fox & Kilsheimer LLP

Kaplan Fox Continues to Investigate Potential Securities Fraud at Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) - INVESTOR UPDATE

NEW YORK, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is continuing to investigate claims on behalf of investors in Spectrum Pharmaceuticals, Inc....
November 25, 2022 10:59 ET | Source: Kaplan Fox & Kilsheimer LLP

Kaplan Fox Continues to Investigate Potential Securities Fraud at Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) - INVESTOR UPDATE

NEW YORK, Nov. 25, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is continuing to investigate claims on behalf of investors in Spectrum Pharmaceuticals, Inc....
November 21, 2022 18:16 ET | Source: Kaplan Fox & Kilsheimer LLP

Kaplan Fox Investigates Potential Securities Fraud at Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI)

NEW YORK, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors in Spectrum Pharmaceuticals, Inc. (“Spectrum” or the...
November 11, 2022 20:00 ET | Source: Kaplan Fox & Kilsheimer LLP

SPPI Investor Alert: Kaplan Fox Investigates Potential Securities Fraud at Spectrum Pharmaceuticals, Inc.

NEW YORK, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors in Spectrum Pharmaceuticals, Inc. (“Spectrum” or the...

Next Page keyboard_arrow_right